VIDEO: Dr. Ian de Boer discusses impact of CKD on cardiometabolic disease

Dr. de Boer, a professor of medicine and associate director of the Kidney Research Institute at the University of Washington in Seattle, told Healio Nephrology that “CKD is common, complicating type 1 and type 2 diabetes and the cardiometabolic syndrome, and also markedly increases the risk of cardiovascular disease, including cardiac failure.”

Screening for CKD among patients with diabetes  “is absolutely important” to detect kidney damage early, de Boer said. “It is morbid, we do have treatments and screening can help us determine who will benefit from these treatments,” he said.